SCHEMBL5773476

SCHEMBL5773476

O=C(N(CCCc1cnoc1-c1ccc(C(F)(F)F)cc1)C1CCN(Cc2ccccc2)C1)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
KCNH2 Q12809 1/20 0.43
CHRM4 P08173 5/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
BCHE P06276 4/20 0.41
ACHE P22303 4/20 0.41
BACE1 P56817 4/20 0.41
SIGMAR1 Q99720 2/20 0.41
UBE2M P61081 1/20 0.38
DCUN1D1 Q96GG9 1/20 0.38
CYP3A4 P08684 1/20 0.38
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771825 0.95 KCNH2 (0.47) DRD2DRD4KCNH2CHRM4BCHE
SCHEMBL5771833 0.94 DRD2 (0.42) DRD2DRD4CHRM4HDAC3HDAC4
Trifluoroacetic Acid SCHEMBL5773674 0.80 OPRM1 (0.47) DRD2DRD4UBE2MDCUN1D1OPRM1
SCHEMBL5774218 0.79 OPRM1 (0.50) DRD2DRD4UBE2MDCUN1D1OPRM1
Trifluoroacetic Acid SCHEMBL5773475 0.78 DRD4 (0.58) DRD2DRD4HDAC3HDAC4HDAC7
Trifluoroacetic Acid SCHEMBL5774584 0.78 MEN1 (0.44) DRD2DRD4KCNH2CHRM4HDAC3
SCHEMBL5774454 0.77 SIGMAR1 (0.41) CHRM4ACHESIGMAR1
Trifluoroacetic Acid SCHEMBL5771823 0.76 SIGMAR1 (0.58) DRD2DRD4CHRM4BCHEACHE
SCHEMBL5776141 0.75 TRPV1 (0.37)
Trifluoroacetic Acid SCHEMBL5771830 0.73 DRD2 (0.54) DRD2DRD4HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR DRD2 2788/4885DRD4 2268/4885KCNH2 1149/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 DRD2 2833/4885DRD4 2538/4885KCNH2 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.